1. Duran CG, Pomar JL, Revuelta JM, et al. Conservative operation for mitral insufficiency: critical analysis supported by postoperative hemodynamic studies of 72 patients. J Thorac Cardiovasc Surg 1980;79:326-337.
2. Enriquez-Sarano M, Schaff HV, Orszulak TA, et al. Valve repair improves the outcome of surgery for mitral regurgitation. A multivariate analysis. Circulation 1995;91:1022-1028.
3. 循環器病の診断と治療に関するガイドライン. 弁膜疾患の非薬物治療に関するガ イドライン(2012 年改訂版). http://www.j-circ.or.jp/guideline/pdf/JCS2012_ookita_h.pdf
4. Nishimura RA, Otto CM, Bonow RO, et al. 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol2017;70:252-89.
5. STS online risk calculator. Available at: http://riskcalcstsorg/stswebriskcalc Accessed January 20, 2017.
6. Braunberger E, Deloche A, Berrebi A, et al. Very long-term results (more than 20 years) of valve repair with Carpentier’s techniques in non-rheumatic mitral valve insufficiency. Circulation.2001;104:I8–11.
7. Cohn LH. Surgery for mitral regurgitation. JAMA. 1988;260:2883–7.
8. Cosgrove DM, Chavez AM, Lytle BW, et al. Results of mitral valve reconstruction. Circulation. 1986;74:I82–7.
9. David TE, Uden DE, Strauss HD. The importance of the mitral apparatus in left ventricular function after correction of mitral regurgitation. Circulation. 1983;68:II76–82.
10. David TE, Burns RJ, Bacchus CM, Druck MN. Mitral valve replacement for mitral regurgitation with and without preservation of chordae tendineae. J Thorac Cardiovasc Surg. 1984;88:718–25.
11. David TE, Ivanov J, Armstrong S, et al. A comparison of outcomes of mitral valve repair for degenerative disease with posterior, anterior, and bileaflet prolapse. J Thorac Cardiovasc Surg. 2005;130:1242–9.
12. Gammie JS, Sheng S, Griffith BP, et al. Trends in mitral valve surgery in the United States: results from the Society of Thoracic Surgeons Adult Cardiac Surgery Database. Ann Thorac Surg. 2009;87:1431–7; discussion 7–349.
13. Goldman KE. Dental management of patients with bone marrow and solid organ transplantation. Dent Clin North Am. 2006;50:659–76.
14. Hansen DE, Sarris GE, Niczyporuk MA, et al. Physiologic role of the mitral apparatus in left ventricular regional mechanics, contraction synergy, and global systolic performance. J Thorac Cardiovasc Surg. 1989;97:521–33.
15. Hennein HA, Swain JA, McIntosh CL, et al. Comparative assessment of chordal preservation versus chordal resection during mitral valve replacement. J Thorac Cardiovasc Surg. 1990;99:828–36; discussion 36–7.
16. Horskotte D, Schulte HD, Bircks W, et al. The effect of chordal preservation on late outcome after mitral valve replacement: a randomized study. J Heart Valve Dis. 1993;2:150–8.
17. McClure RS, Athanasopoulos LV, McGurk S, et al. One thousand minimally invasive mitral valve operations: early outcomes, late outcomes, and echocardiographic follow-up. J Thorac Cardiovasc Surg. 2013;145:1199–206.
18. Rozich JD, Carabello BA, Usher BW, et al. Mitral valve replacement with and without chordal preservation in patients with chronic mitral regurgitation. Mechanisms for differences in postoperative ejection performance. Circulation. 1992;86:1718–26.
19. Rushmer RF. Initial phase of ventricular systole: asynchronous contraction. Am J Physiol. 1956;184:188–94.
20. Sarris GE, Cahill PD, Hansen DE, et al. Restoration of left ventricular systolic performance after reattachment of the mitral chordae tendineae. The importance of valvular-ventricular interaction. J Thorac Cardiovasc Surg. 1988;95:969–79.
21. Vassileva CM, Mishkel G, McNeely C, et al. Long-term survival of patients undergoing mitral valve repair and replacement: a longitudinal analysis of Medicare fee-for-service beneficiaries. Circulation. 2013;127:1870–6.
22. Badhwar V, Peterson ED, Jacobs JP, et al. Longitudinal outcome of isolated mitral repair in older patients: results from 14,604 procedures performed from 1991 to 2007. Ann Thorac Surg. 2012;94:1870–9.
23. Bolling SF, Li S, O’Brien SM, et al. Predictors of mitral valve repair: clinical and surgeon factors. Ann Thorac Surg. 2010;90:1904–11; discussion 12.
24. Chauvaud S, Fuzellier JF, Berrebi A, et al. Long-term (29 years) results of reconstructive surgery in rheumatic mitral valve insufficiency. Circulation. 2001;104:I12–5.
25. Chikwe J, Goldstone AB, Passage J, et al. A propensity score adjusted retrospective comparison of early and mid-term results of mitral valve repair versus replacement in octogenarians. Eur Heart J. 2011;32:618–26.
26. Grossi EA, Galloway AC, Miller JS, et al. Valve repair versus replacement for mitral insufficiency: when is a mechanical valve still indicated?. J Thorac Cardiovasc Surg. 1998;115:389–96.
27. David TE, Armstrong S, McCrindle BW, et al. Late outcomes of mitral valve repair for mitral regurgitation due to degenerative disease. Circulation 2013;127:1485–92.
28. McClure RS, Cohn LH, Wiegerinck E, et al. Early and late outcomes in minimally invasive mitral valve repair: an eleven-year experience in 707 patients. J Thorac Cardiovasc Surg 2009;137:70–5.
29. Gillinov AM, Blackstone EH, Nowicki ER, et al. Valve repair versus valve replacement for degenerative mitral valve disease. J Thorac Cardiovasc Surg 2008;135:885–93, 893.e1–2.
30. Suri RM, Schaff HV, Dearani JA, et al. Survival advantage and improved durability of mitral repair for leaflet prolapse subsets in the current era. Ann Thorac Surg 2006;82:819– 26.
31. Lazam S, Vanoverschelde JL, Tribouilloy C, et al. Twenty-year outcome after mitral repair versus replacement for severe degenerative mitral regurgitation: analysis of a large, prospective, multicenter, international registry. Circulation. (2017) 135:410–22.
32. Nishi H, Miyata H, Motomura N, Toda K, Miyagawa S, Sawa Y. et al. Propensity-matched analysis of minimally invasive mitral valve repair using a nationwide surgical database. Surg Today 2015;45:1144–52.
33. Kawamoto S, Miyata H, Motomura N, Tanemoto K, Takamoto S, Saiki Y. Surgical outcomes of isolated coronary artery bypass grafting for acute coronary syndrome—based on the Japan Adult Cardiovascular Surgery Database. Circ J. 2017;82:123–130.
34. Iino K, Miyata H, Motomura N, et al. Prolonged Cross-Clamping During Aortic Valve Replacement Is an Independent Predictor of Postoperative Morbidity and Mortality: Analysis of the Japan Cardiovascular Surgery Database. Ann Thorac Surg. 2017; 103(2):602-609.
35. Falk V, Cheng DCH, Martin J, et al. Minimally invasive versus open mitral valve surgery: a consensus statement of the international society of minimally invasive coronary surgery (ISMICS) 2010. Innovations. 2011;2:66–76.
36. Pibarot P, Dumesnil JG. Prosthesis–patient mismatch: definition, clinical impact, and prevention. Heart. 2006; 92: 1022–1029.
37. Rao V, Jamieson WRE, Ivanov J, et al. Prosthesis-patient mismatch affects survival after aortic valve replacement. Circulation. 2000;102:Ⅲ5-9.
38. Walther T, Rastan A, Falk V, et al. Patient prosthesis mismatch affects short- and long-term outcomes after aortic valve replacement. Eur J Cardiothorac Surg. 2006;30:15– 19.
39. Angeloni E, Melina G, Benedetto U, et al. Impact of prosthesis-patient mismatch on tricuspid valve regurgitation and pulmonary hypertension following mitral valve replacement. Int J Cardiol. 2013; 168: 4150–4.
40. Pibarot P, Magne J, Dumesnil JG. Prosthesis-patient mismatch after mitral valve replacement: back to reality. J Thorac Cardiovasc Surg. 2008; 135: 464–5.
41. Li M, Dumesnil JG, Mathieu P, et al. Impact of valve prosthesis-patient mismatch on pulmonary arterial pressure after mitral valve replacement. J Am Coll Cardiol. 2005;45:1034-40.
42. Lam BK, Chan V, Hendry P, et al. The impact of patient-prosthesis mismatch on late outcomes after mitral valve replacement. J Thorac Cardiovasc Surg. 2007;133:1464-73.
43. Magne J, Mathieu P, Dumesnil JG, et al. Impact of prosthesis-patient mismatch on survival after mitral valve replacement. Circulation. 2007;115:1336-38.
44. Sato S, Fujita T, Shimahara Y, et al. Impact of prosthesis-patient mismatch on late recurrence of atrial fibrillation after cryo-maze procedure with mitral valve replacement. Circ J. 2014;78:1908–14.
45. Kawamoto N, Fujita T, Hata H, et al. Prosthesis-patient mismatch due to small ring annuloplasty in patients with degenerative mitral insufficiency. J Cardiol. 2016;68(2):141-7.
46. Bramer S, van Straten AH, Soliman Hamad MA, et al. New-onset postoperative atrial fibrillation predicts late mortal-ity after mitral valve surgery. Ann Thorac Surg 2011;92:2091–6.
47. Suri RM, Clavel MA, Schaff HV, et al. Effect of recurrent mitral regurgitation following degenerative mitral valve repair: long-term analysis of competing outcomes. J AmColl Cardiol. 2016;67:488-98.
48. Kim JH, Lee SH, Joo HC, et al. Effect of recurrent mitral regurgitation after mitral valve repair in patients with degenerative mitral regurgitation. Circ J. 2017;82:93–101.
49. DiBardino DJ, ElBardissi AW, McClure RS, et al. Four decades of experience with mitral valve repair: analysis of differential indications, technical evolution, and long-term outcome. J Thorac Cardiovasc Surg. 2010;139(1):76-83.
50. Castillo JG, Anyanwu AC, Fuster V, et al. A near 100% repair rate for mitral valve prolapse is achievable in a reference center: implications for future guidelines. J Thorac Cardiovasc Surg. 2012;144:308-12.
51. Kawamoto N, Fujita T, Fukushima S, et al. Should annuloplasty prosthesis be selected dependent on the location of prolapse in mitral valve repair for type II dysfunction? J Thorac Cardiovasc Surg 2017;154:1915–24.
52. Kernis SJ, Nkomo VT, Messika-Zeitoun D, et al. Atrial fibrillation after surgical correction of mitral insufficiency in sinus rhythm: incidence, outcome, and determinants. Circulation 2004;110:2320–5.
53. Kawamoto N, Fujita T, Fukushima S, et al. Late onset of atrial fibrillation in patients undergoing mitral valve repair for type Ⅱ dysfunction. J Cardiol. 2018 ;71:346-351.
54. Chan KL, Chen SY, Chan V, et al. Functional significance of elevated mitral gradients after repair for degenerative mitral regurgitation. Circ Cardiovasc Imaging 2013;6:1041– 7.
55. Munclinger MJ, Patel JJ, Mitha AS. Thrombolysis of thrombosed St. Jude Medical prosthetic valves: rethrombosis--a sign of tissue ingrowth. J Thorac Cardiovasc Surg 1998;115:248–9.
56. Bothe W, Rausch MK, Kvitting JPE, et al. How do annuloplasty rings affect mitral annular strains in the normal beating ovine heart? Circulation 2012;126:S231–8.
57. Kawamoto N, Fujita T, Fukushima S, et al. Functional mitral stenosis after mitral valve repair for Type II dysfunction: determinants and impacts on long-term outcome. Eur J Cardiothorac Surg 2018;54:453-9.
58. Gammie JS, Zhao Y, Peterson ED, et al. Less-invasive mitral valve operations: trends and outcomes from The Society of Thoracic Surgeons Adult Cardiac Surgery Database. Ann Thorac Surg 2010;90:1401–10.
59. Nishi H, et al. Propensity-matched analysis of minimally invasive mitral valve repair using a nationwide surgical database. Surg Today 45 : 1144-52, 2015.
60. Modi P, Hassan A, Chitwood WR. Minimally invasive mitral valve surgery: a systematic review and meta-analysis. Eur J Cardiothorac Surg. 2008;34:943–52.
61. Cheng DCH, Martin J, Lal A, et al. Minimally invasive versus conventional open mitral valve surgery. Innovations. 2011;6:84–103.
62. Cao C, Gupta S, Chandrakumar D, et al. A meta-analysis of minimally invasive versus conventional mitral valve repair for patients with degenerative mitral disease. Ann Cardiothorac Surg. 2013; 2:693–703.
63. Ding C, Jiang DM, Tao KY, et al. Anterolateral minithoracotomy versus median sternotomy for mitral valve disease: a meta-analysis. J Zhejiang Univ Sci B. 2014;15:522–32.
64. Davierwala PM, Seeburger J, Pfannmueller B, et al. Minimally invasive mitral valve surgery: “The Leipzig experience”. Ann Cardiothorac Surg. 2013;2:744–50.
65. Mohr FW, Falk V, Diegeler A, et al. Minimally invasive port access mitral valve surgery. J Thorac Cardiovasc Surg 1998;115:567–76.
66. Glower DD, Siegel LC, Galloway AC, et al. Predictors of operative time in multicenter port-access valve registry: institutional differences in learning. Heart Surg Forum 2001;4:40–6.
67. Wimmer-Greinecker DG, Matheis G, Dogan S, et al. Complications of port-access cardiac surgery. J Card Surg 1999; 14: 240 – 245.
68. Ailawadi G, Agnihotri AK, Mehall JR, et al. Minimally Invasive Mitral Valve Surgery I: Patient Selection, Evaluation, and Planning. Innovations (Phila) 2016;11:243-50.
69. Kawamoto N, Fukushima S, Shimahara Y, et al. Benefit and Risk of Minimally Invasice Mitral Valve Repair for Type Ⅱ dysfunction - Propensity Score-Matched Comparison - . Circ J 2018 ;83(1):224-231
70. January CT, Wann LS, Alpert JS, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2014;64:e1–e76.
71. Bessissow A, Khan J, Devereaux PJ, Alvarez-Garcia J, Alonso-Coello P. Postoperative atrial fibrillation in non-cardiac and cardiac surgery: an overview. J Thromb Haemost. 2015;13(Suppl 1):S304–12.
72. Beunckens C, Molenberghs G, Kenward MG. Direct likelihood analysis versus simple forms of imputation for missing data in randomized clinical trials. Clin Trials 2005;2:379-86.
73. Kernis SJ, Nkomo VT, Messika-Zeitoun D, et al. Atrial fibrillation after surgical correction of mitral insufficiency in sinus rhythm: incidence, outcome, and determinants. Circulation 2004;110:2320–5.
74. Magruder JT, Collica S, Belmustakov S, et al. Predictors of late-onset atrial fibrillation following isolated mitral valve repairs in patients with preserved ejection fraction. J Card Surg 2016;31:486-92.
75. Lim E, Barlow CW, Hosseinpour AR, et al. Influence of atrial fibrillation on outcome following mitral valve repair. Circu-lation 2001;104:159–63.
76. Obadia JF, el Farra M, Bastien OH, et al. Outcome of atrial fibrillation after mitral valve repair. J Thorac Cardiovasc Surg 1997;114:179–85.
77. Jessurun ER, van Hemel NM, Kelder JC, et al. Mitral valve surgery and atrial fibrillation: is atrial fibrillation surgery also needed? Eur J Cardiothorac Surg 2000;17:530–7.
78. Stulak JM, Suri RM, Dearani JA, et al. When should prophylactic maze procedure be considered in patients undergoing mitral valve surgery? Ann Thorac Surg 2010;89:1395– 401.
79. Kirchhof P, Lip GY, Van Gelder IC, et al. Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options - a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference. Euro-pace 2012;14:8–27.
80. Del Campo A, Roldán J, Verdejo HE, et al. Increased C-reactive protein plasma levels are not involved in the onset of post-operative atrial fibrillation. J Cardiol 2017;70:578–83.
81. Park J, Lee SH, Lee JS, et al. High recurrence of atrial fibrillation in patients with high tissue atrial natriuretic peptide and amyloid levels after concomitant maze and mitral valve surgery. J Cardiol 2017;69:345–52.
82. Yamauchi T, Sakata Y, Takada T, et al. Prognostic impacts of new-onset atrial fibrillation in patients with chronic heart failure – A report from the CHART – 2 Study-. Circ J 2016; 80: 157-167.
83. Sato S, Fujita T, Shimahara Y, et al. Impact of prosthesis-patient mismatch on late recurrence of atrial fibrillation after cryomaze procedure with mitral valve replacement. Circ J 2014;78:1908–14.
84. Fujita T, Kobayashi J, Toda K, et al. Long-term outcome of combined valve repair and maze procedure for nonrheumatic mitral insufficiency. J Thorac Cardiovasc Surg 2010;140:1332–7.
85. Vaziri SM, Larson MG, Benjamin EJ, et al. Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study. Circulation 1994;89:724– 30.
86. Psaty BM, Manolio TA, Kuller LH, et al. Incidence of and risk factors for atrial fibrillation in older adults. Circulation 1997;96:2455–61.
87. Fino C, Iacovoni A, Ferrero P, et al. Restrictive mitral valve annuloplasty versus mitral valve replacement for functional ischemic mitral insufficiency: an exercise echocardiographic study. J Thorac Cardiovasc Surg 2014;148. 447–53.e2.
88. Mesana TG, Lam BK, Chan V, et al. Clinical evaluation of functional mitral stenosis after mitral valve repair for degenerative disease: potential affect on surgical strategy. J Thorac Cardiovasc Surg 2013;146:1418–23.
89. Kainuma S, Taniguchi K, Daimon T, et al. Does stringent restrictive annuloplasty for functional mitral regurgitation cause functional mitral stenosis and pulmonary hypertension? Circulation 2011;124:S97–106.
90. Bertrand PB, Gutermann H, Smeets CJ, et al. Functional impact of transmitral gradients at rest and during exercise after restrictive annuloplasty for ischemic mitral regurgitation. J Thorac Cardiovasc Surg 2014;148:183–7.
91. Ibrahim MF, David TE. Mitral stenosis after mitral valve repair for nonrheumatic mitral regurgitation. Ann Thorac Surg 2002;73:34–6.
92. Witschey WR, Zhang D, Contijoch F, et al. The influence of mitral annuloplasty on left ventricular flow dynamics. Ann Thorac Surg 2015;100:114–21.
93. Kupferschmid JP, Carr T, Connelly GP, et al. Systolic anterior motion of the mitral valve after valve repair without an annular ring. Ann Thorac Surg 1994;57:484–6.
94. Bothe W, Kuhl E, Kvitting JE, et al. Rigid, complete annuloplasty rings increase anterior mitral leaflet strains in the normal beating ovine heart. Circulation 2011;124:S81-96.
95. Capoulade R, Zeng X, Overbey JR, Ailawadi G, Alexander JH, Ascheim D, et al. Cardiothoracic surgical trials network (CTSN) investigators. Impact of left ventricular to mitral valve ring mismatch on recurrent ischemic mitral regurgitation after ring annuloplasty. Circulation. (2016) 134:1247–56.
96. Svensson LG, Atik FA, Cosgrove DM, et al. Minimally invasive versus conventional mitral valve surgery: a propensity-matched comparison. J Thorac Cardiovasc Surg 2010;139:926–32.
97. Hausenloy DJ, Boston-Griffiths E, Yellon D. Cardioprotection during cardiac surgery. Cardiovasc Res 2012;94:253-65.
98. Buckberg G. Antegrade/retrograde blood cardioplegia to ensure cardioplegic distribution: Operative techniques and objectives. J Cardiac Surg 1989;4:216-238.
99. Hilton C, Teubl W, Acker M, et al. Inadequate cardioplegic protection with obstructed coronary arteries. Ann Thorac Surg 1979;28:323-34.
100. Becker H, Vinten-Johansen J, Buckberg GD, et al. Critical importance of ensuring cardioplegic delivery with coronary stenoses. J Thorac Cardiovasc Surg 1981;81:507-15.
101. Mick SL, Robich MP, Houghtaling PL, et al. Del Nido versus Buckberg cardioplegia in adult isolated valve surgery. J Thorac Cardiovasc Surg 2015;149:626-34
102. Freed LA, Levy D, Levine RA, et al. Prevalence and clinical outcome of mitral valve prolapse. N Engl J Med. 1999;341:1-7.
103. Levine RA, Stathogiannis E, Newell JB, et al. Reconsideration of echocardiographic standards for mitral valve prolapse: Lack of association between leaflet displacement isolated to the apical four chamber view and independent echocardiographic evidence of abnormality. Journal of the American College of Cardiology. 1988; 11(5):1010-1019.
104. Jensen MO, Hagege AA, Otsuji Y, et al. The unsaddled annulus: biomechanical culprit in mitral valve prolapse? Circulation. 2013;127(7):766–768.
105. Lee AP, Hsiung MC, Salgo IS, et al. Quantitative analysis of mitral valve morphology in mitral valve prolapse with real-time 3-dimensional echocardiography: importance of annular saddle shape in the pathogenesis of mitral regurgitation. Circulation. 2013;127(7):832–841.
106. Grewal J, Suri R, Mankad S, et al. Mitral annular dynamics in myxomatous valve disease: new insights with real time three dimensional echocardiography. Circulation. 2010;121(12):1423–1431.
107. Nesta F, Leyne M, Yosefy C, et al. New locus for autosomal dominant mitral valve prolapse on chromosome 13: clinical insights from genetic studies. Circulation. 2005;112:2022–30.
108. Carpentier A, Guerinon J, Deloche A, et al. THE Mitral Valve: A Pluridisciplinary Approach. Kalmanson D editor. Acton, MA: Publishing Sciences Group Inc.; 1976.
109. Carpentier A, Lacour-Gayet F, Camilleri J. Fibroelastic dysplasia of the mitral valve: an anatomical and clinical entity. Circulation. 1982;3:307.
110. Disse S, Abergel E, Berrebi A, et al. Mapping of a first locus for autosomal dominant myxomatous mitral-valve prolapse to chromosome 16p11.2-p12.1. Am J Hum Genet. 1999;65:1242–51.
111. Fornes P, Heudes D, Fuzellier JF, et al. Correlation between clinical and histologic patterns of degenerative mitral valve insufficiency: a histomorphometric study of 130 excised segments. Cardiovasc Pathol. 1999;8(2):81–92.
112. Rabkin E, Aikawa M, Stone JR, et al. Activated interstitial myofibroblasts express catabolic enzymes and mediate matrix remodeling in myxomatous heart valves. Circulation. 2001;104:2525–32.
113. Briffa N. Surgery for degenerative mitral valve disease. BMJ. 2010;341:c5339.
114. Barlow JB, Bosman CK. Aneurysmal protrusion of the posterior leaflet of the mitral valve. An auscultatory-electrocardiographic syndrome. Am Heart J. 1966;71:166–78.
115. Gulotta SJ, Gulco L, Padmanabhan V, et al. The syndrome of systolic click, murmur, and mitral valve prolapse—a cardiomyopathy? Circulation. 1974; 49:717–28.
116. Reduto LA, Gulotta SJ. Cardiology: prolapsed mitral valve syndrome. Postgrad Med. 1976;60:171–6.
117. Barlow JB, Pocock WA. The significance of late systolic murmurs and mid-late systolic clicks. Md State Med J. 1963;12:76–7.
118. Adams DH, Anyanwu AC, Rahmanian PB, et al. Large annuloplasty rings facilitate mitral valve repair in Barlow’s disease. Ann Thorac Surg. 2006;82:2096–100.
119. Ng CM, Cheng A, Myers LA, et al. TGF-beta-dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome. J Clin Invest. 2004;114:1586–92.
120. David TE, Omran A, Armstrong S, et al. Long-term results of mitral valve repair for myxomatous disease with and without chordal replacement with expanded polytetrafluoroethylene sutures. J Thorac Cardiovasc Surg. 1998;115:1279–85.
121. Freed LA, Acierno JS Jr, Dai D, et al. A locus for autosomal dominant mitral valve prolapse on chromosome 11p15.4. Am J Hum Genet. 2003;72:1551-9.
122. Guilherme L, Fae K, Oshiro SE, et al. Molecular pathogenesis of rheumatic fever and rheumatic heart disease. Expert Rev Mol Med. 2005;7:1-15.
123. Fae KC, da Silva DD, Oshiro SE, et al. Mimicry in recognition of cardiac myosin peptides by heart-intralesional T cell clones from rheumatic heart disease. J Immunol. 2006;176:5662-70.
124. Cunningham MW. Streptococcus and rheumatic fever. Current opinion in rheumatology. 2012;24(4):408–416.
125. Marcus RH, Sareli P, Pocock WA, et al. Functional anatomy of severe mitral regurgitation in active rheumatic carditis. The American Journal of Cardiology. 1989;63(9):577–584
126. Marcus RH, Sareli P, Pocock WA, et al. The spectrum of severe rheumatic mitral valve disease in a developing country. Correlations among clinical presentation, surgical pathologic findings, and hemodynamic sequelae. Ann Intern Med. 1994;120(3):177–183.
127. McKusick VA. Heritable Disorders of Connective Tissue. Fourth ed. C. V. Mosby Company; 1972.
128. Loeys BL, Chen J, Neptune ER, et al. A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. Nat Genet. 2005;37(3):275–281.
129. Kyndt F, Gueffet JP, Probst V, et al. Mutations in the gene encoding filamin A as a cause for familial cardiac valvular dystrophy. Circulation. 2007;115(1):40–49.
130. Kyndt F, Schott J-J, Trochu J-N, et al. Mapping of X-Linked Myxomatous Valvular Dystrophy to Chromosome Xq28. The American Journal of Human Genetics. 1998;62(3):627–632.
131. Nakamura F, Stossel TP, Hartwig JH. The filamins: Organizers of cell structure and function. Cell Adh Migr. 2011;5(2):160–169.
132. Piper C, Hetzer R, Korfer R, et al. The importance of secondary mitral valve involvement in primary aortic valve endocarditis; the mitral kissing vegetation. Eur Heart J. 2002;23:79-86.
133. Habib G, Lancellotti P, Antunes MJ, et al. ESC Scientific Document Group. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 2015;36:3075-128.
134. Otsuji Y, Handschumacher MD, Schwammenthal E, et al. Insights from three-dimensional echocardiography into the mechanism of functional mitral regurgitation: direct in vivo demonstration of altered leaflet tethering geometry. Circulation. 1997;96(6):1999–2008.
135. Kaul S, Spotnitz WD, Glasheen WP, et al. Mechanism of ischemic mitral regurgitation. An experimental evaluation. Circulation. 1991;84(5):2167–2180.
136. Kono T, Sabbah HN, Rosman H, et al. Left ventricular shape is the primary determinant of functional mitral regurgitation in heart failure. J Am Coll Cardiol. 1992;20(7):1594–1598.
137. Sabbah HN, Kono T, Stein PD, et al. Left ventricular shape changes during the course of evolving heart failure. Am J Physiol. 1992;263(1 Pt 2):H266–70.
138. Sabbah HN, Rosman H, Kono T, et al. On the mechanism of functional mitral regurgitation. Am J Cardiol. 1993;72(14):1074–76.
139. Perloff JK, Roberts WC. The mitral apparatus. Functional anatomy of mitral regurgitation. Circulation. 1972;46(2):227–39.
140. Silverman ME, Hurst JW. The mitral complex. Interaction of the anatomy, physiology, and pathology of the mitral annulus, mitral valve leaflets, chordae tendineae, and papillary muscles. Am Heart J. 1968;76(3):399–418.
141. Godley RW, Wann LS, Rogers EW, et al. Incomplete mitral leaflet closure in patients with papillary muscle dysfunction. Circulation. 1981;63(3):565–571.
142. Ogawa S, Hubbard FE, Mardelli TJ, et al. Cross-sectional echocardiographic spectrum of papillary muscle dysfunction. Am Heart J. 1979;97(3):312–321.
143. Chaput M, Handschumacher MD, Guerrero JL, et al. Mitral leaflet adaptation to ventricular remodeling: prospective changes in a model of ischemic mitral regurgitation. Circulation. 2009;120(11 Suppl):S99–S103.
144. Chaput M, Handschumacher MD, Tournoux F, et al. Mitral leaflet adaptation to ventricular remodeling: occurrence and adequacy in patients with functional mitral regurgitation. Circulation. 2008;118(8):845–852.
145. Gillam LD. Is it time to update the definition of functional mitral regurgitation?: structural changes in the mitral leaflets with left ventricular dysfunction. Circulation. 2008;118(8):797–799.
146. Dal-Bianco JP, Aikawa E, Bischoff J, et al. Mitral Valve Adaptation is Augmented in Myocardial Infarction: A Three-Dimensional Echocardiographic-Histopathologic Follow-Up Study. Journal of the American Society of Echocardiography. 2009;22(5):544.
147. Grande-Allen KJ, Barber JE, et al. Mitral valve stiffening in end-stage heart failure: evidence of an organic contribution to functional mitral regurgitation. J Thorac Cardiovasc Surg. 2005;130(3):783–790.
148. Grande-Allen KJ, Borowski AG, Troughton RW, et al. Apparently normal mitral valves in patients with heart failure demonstrate biochemical and structural derangements: an extracellular matrix and echocardiographic study. J Am Coll Cardiol. 2005;45(1):54– 61.
149. Beaudoin J, Handschumacher MD, Zeng X, et al. Mitral valve enlargement in chronic aortic regurgitation as a compensatory mechanism to prevent functional mitral regurgitation in the dilated left ventricle. Journal of the American College of Cardiology. 2013;61(17):1809–16.
150. Balachandran K, Alford PW, Wylie-Sears J, et al. Cyclic strain induces dual-mode endothelial-mesenchymal transformation of the cardiac valve. Proc Natl Acad Sci U S A. 2011;108(50):19943–48.
151. Dal-Bianco JP, Aikawa E, Bischoff J, et al. Active adaptation of the tethered mitral valve: insights into a compensatory mechanism for functional mitral regurgitation. Circulation. 2009;120(4):334–42.
152. Beaudoin JD-BJ, Aikawa E, Biscoff J, et al. Mitral leaflet changes following myocardial infarction: evidence for maladaptive remodeling favoring ischemic mitral regurgitation. J Am Coll Cardiol. 2012;59(13s1):E2136–E2136.
153. Stephens EH, Timek TA, Daughters GT, et al. Significant changes in mitral valve leaflet matrix composition and turnover with tachycardia-induced cardiomyopathy. Circulation. 2009;120(11 Suppl):S112–S119.
154. Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 2014;63:e57-e185.
155. Zoghbi WA, Enriquez-Sarano M, Foster E, et al. Recommendations for evaluation of the severity of native valvular regurgitation with two dimensional and Doppler echocardiography. J Am Soc Echocardiogr. 2003;16:777–802.
156. Enriquez-Sarano M, Avierinos JF, Messika-Zeitoun D, et al. Quantitative determinants of the outcome of asymptomatic mitral regurgitation. N Engl J Med. 2005;352:875–83.
157. Enriquez-Sarano M, Tajik AJ, Schaff HV, et al. Echocardiographic prediction of survival after surgical correction of organic mitral regurgitation. Circulation. 1994;90:830–7.
158. Lang RM, Badano LP, Tsang W, et al. EAE/ASE recommendations for image acquisition and display using three-dimensional echocardiography. J Am Soc Echocardiogr. 2012;25:3–46.
159. Witkowski TG, Thomas JD, Debonnaire PJ, et al. Global longitudinal strain predicts left ventricular dysfunction after mitral valve repair. Eur Heart J Cardiovasc Imaging. 2013;14:69–76.
160. Magne J, Mahjoub H, Pierard LA, et al. Prognostic importance of brain natriuretic peptide and left ventricular longitudinal function in asymptomatic degenerative mitral regurgitation. Heart. 2012;98:584–91.
161. Pflugfelder PW, Sechtem UP, White RD, et al. Noninvasive evaluation of mitral regurgitation by analysis of left atrial signal loss in cine magnetic resonance. Am Heart J. 1989;117:1113–9.
162. Ozdogan O, Yuksel A, Gurgun C, et al. Evaluation of the severity of mitral regurgitation by the use of signal void in magnetic resonance imaging. Echocardiography. 2009;26:1127–35.
163. Myerson SG, Francis JM, Neubauer S. Direct and indirect quantification of mitral regurgitation with cardiovascular magnetic resonance, and the effect of heart rate variability. MAGMA. 2010;23:243–9.
164. Monin JL, Dehant P, Roiron C, et al. Functional assessment of mitral regurgitation by transthoracic echocardiography using standardized imaging planes diagnostic accuracy and outcome implications. J Am Coll Cardiol 2005;46:302–309.
165. Baumgartner H, Falk V, Bax JJ, et al. ESC/EACTS guideline for the management of valvular heart disease: the task force for the management of valvular heart disease of the European Society of Cardiology (ESC) and European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2017:2739-86.
166. Lancellotti P, Gerard PL, Pierard LA. Long-term outcome of patients with heart failure and dynamic functional mitral regurgitation. Eur Heart J 2005;26:1528–1532.
167. Magne J, Lancellotti P, Pierard LA. Exercise pulmonary hypertension in asymptomatic degenerative mitral regurgitation. Circulation 2010;122:33–41.
168. Pizarro R, Bazzino OO, Oberti PF, et al. Prospective validation of the prognostic usefulness of brain natriuretic peptide in asymptomatic patients with chronic severe mitral regurgitation. J Am Coll Cardiol 2009;54:1099–1106.
169. Grigioni F, Enriquez-Sarano M, Zehr KJ, et al. Ischemic mitral regurgitation: long-term outcome and prognostic implications with quantitative Doppler assessment. Circulation 2001;103:1759–1764.
170. Bonow RO, Carabello B, de Leon ACJ, et al. Guidelines for the management of patients with valvular heart disease: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease). Circulation 1998;98:1949-84.
171. Crawford MH, Souchek J, Oprian CA, et al. Determinants of survival and left ventricular performance after mitral valve replacement. Department of Veterans Affairs Cooperative Study on Valvular Heart Disease. Circulation 1990; 81: 1173- 81.
172. Phillips HR, Levine FH, Carter JE, et al. Mitral valve replacement for isolated mitral regurgitation: analysis of clinical course and late postoperative left ventricular ejection fraction. Am J Cardiol 1981; 48: 647-54.
173. Schuler G, Peterson KL, Johnson A, et al. Temporal response of left ventricular performance to mitral valve surgery. Circulation 1979; 59: 1218-31.
174. Wisenbaugh T, Skudicky D, Sareli P. Prediction of outcome after valve replacement for rheumatic mitral regurgitation in the era of chordal preservation. Circulation 1994;89:191-7.
175. Enriquez-Sarano M, Tajik AJ, Schaff HV, et al. Echocardiographic prediction of left ventricular function after correction of mitral regurgitation: results and clinical implications. J Am Coll Cardiol 1994;24:1536-43.
176. Flemming MA, Oral H, Rothman ED, et al. Echocardiographic markers for mitral valve surgery to preserve left ventricular performance in mitral regurgitation. Am Heart J 2000;140:476-82.
177. Zile MR, Gaasch WH, Carroll JD, et al. Chronic mitral regurgitation: predictive value of preoperative echocardiographic indexes of left ventricular function and wall stress. J Am Coll Cardiol 1984;3(2 Pt 1):235-42.
178. Tabata M, Kasegawa H, Fukui T, et al. S. Long-term outcomes of artificial chordal replacement with tourniquet technique in mitral valve repair: a single-center experience of 700 cases. J Thorac Cardiovasc Surg. 2014;148(5):2033-2038.
179. Yaffee DW, Loulmet DF, Zias EA, et al. Long-term results of mitral valve repair with semi-rigid posterior band annuloplasty. J Heart Valve Dis. 2014;23(1):66-71.
180. David TE, Armstrong S, Ivanov J. Chordal replacement with polytetrafluoroethylene sutures for mitral valve repair: a 25-year experience. J Thorac Cardiovasc Surg. 2013;145:1563-1569.
181. De Bonis M, Lapenna E, Taramasso M, et al. Very long-term durability of the edge-to-edge repair for isolated anterior mitral leaflet prolapse: up to 21 years of clinical and echocardiographic results. J Thorac Cardiovasc Surg. 2014;148(5):2027-2032.
182. Coutinho GF, Correia PM, Branco C, et al. Long-term results of mitral valve surgery for degenerative anterior leaflet or bi-leaflet prolapse: analysis of negative factors for repair, early and late failures, and survival. Eur J Cardiothorac Surg. 2016;50(1):66-74.
183. Seeburger J, Borger MA, Falk V, et al. Minimal invasive mitral valve repair for mitral regurgitation: results of 1339 consecutive patients. Eur J Cardiothorac Surg. 2008;34(4):760-65.
184. De Bonis M, Alfieri O, Dalrymple-Hay M, et al. Mitral valve repair in degenerative mitral regurgitation: State of the Art. Prog Cardiovasc Dis. 2017;60(3):386–93.
185. Gillinov AM, Cosgrove DM, Blackstone EH, et al. Durability of mitral valve repair for degenerative disease. J Thorac Cardiovasc Surg. 1998;116(5):734-43.
186. Nair RU, et al. Left ventricular volume reduction without ventriculectomy. Ann Thorac Surg 71. 2046-49, 2001.
187. Kron IL, et al. Surgical relocation of the posterior papillary muscle in chronic ischemic mitra l regurgitation. Ann Thorac Surg 74:600-1, 2002.
188. Messas E, et al. Chordal cutting: a new therapeutic approach for ischemic mitral regurgitation. Circulation 104:1958-63, 2001.
189. Acker MA, et al. Mitral valve repair versus replacement for severe ischemic mitral regurgitation. N Engl J Med 370:23-32, 2014.
190. Kron IL, et al. Predicting recurrent mitral regurgitation after mitral valve repair for severe ischemic mitral regurgitation. J Thorac Cardiovasc Surg 149:752-61, 2015. 191. Smith PK, et al. Surgical treatment of moderate ischemic mitral regurgitation. N Engl J Med 371:2178-88, 2014.
論文の公開元へ
